©2018 by The Meisel and The Hinterleitner Lab. Proudly created with Wix.com

MEISEL LAB

In 1907, the Russian scientist and Nobel Laureate Ilya Ilyich Mechnikov (Elie Mechnikov) proposed that ‘many diseases which lead to chronic systemic inflammation, occurred as a result of increased gut bacterial translocation into peripheral organs’ [P., M. E. G. The Prolongation of Life: Optimistic Studies. Putnam's Sons (1907)].

Today, we still only know that gut bacterial translocation is associated with many diseases, such as liver fibrosis, inflammatory bowel disease (IBD), metabolic disease (obesity, diabetes), HIV and cancer. Yet, there is a lack of cause-effect studies.


These early hypotheses by Elie Mechnikov, combined with my previous studies and recent advances in the field of host-microbe interactions inspired me to interrogate how the gut microbiota affects the immune system of the host during health and disease. 

 

CONTACT

200 Lothrop St, Pittsburgh, PA 15213